People
Albert L. Kraus
Albert L. Kraus is published by SSI Strategy as NDA regulatory advisory expert. Regulatory drug-development advisor with oncology, rare-disease and immunology experience, including earlier Pfizer work and published GDS Partners leadership.
Roles
SSI Strategy
CurrentNDA regulatory advisory expert